Search

Your search keyword '"Hou JZ"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Hou JZ" Remove constraint Author: "Hou JZ"
72 results on '"Hou JZ"'

Search Results

3. Developing critical HIV health literacy: insights from interviews with priority migrant communities in Queensland, Australia.

4. [Analysis of a family with 11β-hydroxylase deficiency due to a mutation in the CYP11B1 gene].

5. Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.

6. Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.

7. Association between micronutrients intake and metabolic-associated fatty liver disease: a cross-sectional study based on the National Health and Nutrition Examination Survey.

8. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.

9. Hexacyclic Chelated Lithium Stable Solvates for Highly Reversible Cycling of High-Voltage Lithium Metal Battery.

10. Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

11. Autoimmune gastritis with a gastric hamartomatous inverted polyp and two hyperplastic polyps: a case report.

13. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.

14. A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

15. The Direct Anterior Approach versus the Posterolateral Approach on the Outcome of Total Hip Arthroplasty: A Retrospective Clinical Study.

16. Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.

17. A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.

18. Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.

20. 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150).

21. Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.

22. Comparing the efficacy and safety of local-regional treatments for hepatocellular carcinoma with portal/hepatic vein tumor thrombosis in China: a network meta-analysis of randomized controlled trials.

23. [Application value of liquid crystal digital display goniometer in total hip arthroplasty].

24. Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.

25. Proprioceptive training on the recovery of total knee arthroplasty patients: A meta-analysis protocol of randomized controlled trial.

26. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.

27. Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.

28. Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy.

29. Direct anterior versus lateral approaches for clinical outcomes after total hip arthroplasty: a meta-analysis.

30. Location matters in early stage nodal diffuse large B-cell lymphoma.

31. Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation.

32. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.

33. A systematic review and meta-analysis of direct anterior approach versus posterior approach in total hip arthroplasty.

34. Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

35. Toll-like receptor 4 and its associated proteins as prognostic factors for HCC treated by post-radiotherapy surgery.

36. Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.

38. MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing β-catenin nuclear accumulation.

39. Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.

40. Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

41. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.

42. [Application of microscopic spectroscopy in quality control of Niuhuang Qingxin pills].

43. ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia.

44. High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.

45. Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.

46. [Characteristics and Risk Assessment of Heavy Metals in Core Sediments from Lakes of Tibet].

47. Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.

48. Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.

49. Hypomethylating Agents for Relapse after Allogeneic Hematopoietic Cell Transplantation in Myeloid Malignancies: A Case Series and Review of the Literature.

50. Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse.

Catalog

Books, media, physical & digital resources